E
The startup utilizes metabolomic, genomic, and clinical data analysis from archived navy dolphin samples to identify safe and effective therapies for both human and animal health. By leveraging this unique dataset, the company aims to enhance therapeutic discovery and improve global health outcomes.
San Diego, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup utilizes metabolomic, genomic, and clinical data analysis from archived navy dolphin samples to identify safe and effective therapies for both human and animal health. By leveraging this unique dataset, the company aims to enhance therapeutic discovery and improve global health outcomes.